127 related articles for article (PubMed ID: 23721228)
21. Pediatric HIV type 1 vaccine trial acceptability among mothers in Kenya.
Farquhar C; John-Stewart GC; John FN; Kabura MN; Kiarie JN
AIDS Res Hum Retroviruses; 2006 Jun; 22(6):491-5. PubMed ID: 16796522
[TBL] [Abstract][Full Text] [Related]
22. Building collaborative networks for HIV/AIDS vaccine development: the AVIP experience.
Ferrantelli F; Buttò S; Cafaro A; Wahren B; Ensoli B
Springer Semin Immunopathol; 2006 Nov; 28(3):289-301. PubMed ID: 16983452
[TBL] [Abstract][Full Text] [Related]
23. Who will enroll? Predicting participation in a phase II AIDS vaccine trial.
Halpern SD; Metzger DS; Berlin JA; Ubel PA
J Acquir Immune Defic Syndr; 2001 Jul; 27(3):281-8. PubMed ID: 11464149
[TBL] [Abstract][Full Text] [Related]
24. Pilot study assessing HIV vaccine trial readiness among female sex workers, injection and non-injection drug users, and men who have sex with men in Spain.
Etcheverry MF; de Lazzari E; Fuchs JD; Meroño M; Sierra E; Del Romero J; Evans JL; Mendez-Arancibia E; Jacques C; Rojas D; Segú M; Gatell JM; Joseph J
AIDS Behav; 2010 Jun; 14(3):607-17. PubMed ID: 19037720
[TBL] [Abstract][Full Text] [Related]
25. The HVTN503/Phambili HIV vaccine trial: a comparison of younger and older participants.
Volk JE; Hessol NA; Gray GE; Kublin JG; Churchyard GJ; Mlisana K; Nchabeleng M; Buchbinder SP; Bekker LG
Int J STD AIDS; 2014 Apr; 25(5):332-40. PubMed ID: 24104693
[TBL] [Abstract][Full Text] [Related]
26. Unmet ethical concerns of the proposed preventive HIV vaccine trials in India.
Thomas J
Indian J Med Ethics; 2004; 1(3):87-8. PubMed ID: 16370087
[No Abstract] [Full Text] [Related]
27. The Influence of Community Members on Participation by Youth in an HIV Vaccine Trial in Tanzania.
Mbunda T; Tarimo EA; Chalamilla G; Bakari M; Sandström E; Kulane A
PLoS One; 2016; 11(12):e0168660. PubMed ID: 27997617
[TBL] [Abstract][Full Text] [Related]
28. Cognitive factors and willingness to participate in an HIV vaccine trial among HIV-negative injection drug users.
Dhalla S; Poole G; Singer J; Patrick DM; Wood E; Kerr T
Vaccine; 2010 Feb; 28(7):1663-7. PubMed ID: 20044049
[TBL] [Abstract][Full Text] [Related]
29. Scaling HIV vaccine attitudes among gay men in Sydney, Australia.
Van De Ven P; Bartholow B; Rawstorne P; Crawford J; Kippax S; Grulich A; Prestage G; Woodhouse M; Murphy D
AIDS Res Hum Retroviruses; 2002 Dec; 18(18):1333-7. PubMed ID: 12487804
[TBL] [Abstract][Full Text] [Related]
30. Correlates of HIV vaccine trial participation: an Indian perspective.
Sahay S; Mehendale S; Sane S; Brahme R; Brown A; Charron K; Beyrer C; Bollinger R; Paranjape R
Vaccine; 2005 Feb; 23(11):1351-8. PubMed ID: 15661383
[TBL] [Abstract][Full Text] [Related]
31. HIV-vaccine research and development in Thailand: evolution and challenges.
Pitisuttithum P; Choopanya K; Rerk-Ngnam S
Vaccine; 2010 May; 28 Suppl 2():B45-9. PubMed ID: 20510743
[TBL] [Abstract][Full Text] [Related]
32. HIV-1 prophylactic vaccine trials in Thailand.
Pitisuttithum P
Curr HIV Res; 2005 Jan; 3(1):17-30. PubMed ID: 15638720
[TBL] [Abstract][Full Text] [Related]
33. Acceptability of HIV vaccine trials in high-risk heterosexual cohorts in Mombasa, Kenya.
Jackson DJ; Martin HL; Bwayo JJ; Nyange PM; Rakwar JP; Kashonga F; Mandaliya K; Ndinya-Achola JO; Kreiss JK
AIDS; 1995 Nov; 9(11):1279-83. PubMed ID: 8561982
[TBL] [Abstract][Full Text] [Related]
34. Using surrogate vaccines to assess feasibility and acceptability of future HIV vaccine trials in men: a randomised trial in inner-city Johannesburg, South Africa.
Chimoyi L; Kamndaya M; Venables E; von Knorring N; Stadler J; MacPhail C; Chersich MF; Rees H; Delany-Moretlwe S
BMC Public Health; 2017 Jul; 17(Suppl 3):524. PubMed ID: 28832280
[TBL] [Abstract][Full Text] [Related]
35. Remarks spoken before the audience at the final conference plenary session, entitled: "Future directions," at the International Conference on Advances in AIDS Vaccine Development. Fourth annual meeting of the National Cooperative Vaccine Development Groups for AIDS.
Nzila N
AIDS Res Hum Retroviruses; 1992 Aug; 8(8):1521-2. PubMed ID: 1466995
[TBL] [Abstract][Full Text] [Related]
36. HIV Vaccine Trial participation in South Africa - an ethical assessment.
Moodley K
J Med Philos; 2002 Apr; 27(2):197-215. PubMed ID: 11961697
[TBL] [Abstract][Full Text] [Related]
37. Even an HIV vaccine may not mean the end of AIDS.
Muula AS
Bull World Health Organ; 2001; 79(3):269. PubMed ID: 11285679
[No Abstract] [Full Text] [Related]
38. HIV vaccine preparedness studies in the organization for economic co-operation and development (OECD) countries.
Dhalla S; Woods R; Strathdee SA; Patrick DM; Hogg RS
AIDS Care; 2007 Oct; 19(9):1118-27. PubMed ID: 17851989
[TBL] [Abstract][Full Text] [Related]
39. Microbicide research in developing countries: have we given the ethical concerns due consideration?
Moodley K
BMC Med Ethics; 2007 Sep; 8():10. PubMed ID: 17877834
[TBL] [Abstract][Full Text] [Related]
40. The challenges of HIV vaccine development and testing.
Burgers WA; Williamson C
Best Pract Res Clin Obstet Gynaecol; 2005 Apr; 19(2):277-91. PubMed ID: 15778116
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
